» Authors » Md Ahad Ali

Md Ahad Ali

Explore the profile of Md Ahad Ali including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 9
Citations 5
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Mamun T, Ali M, Hosen M, Rahman J, Islam M, Akib M, et al.
Front Immunol . 2025 Jan; 15():1364129. PMID: 39840071
Human rhinovirus C (HRV-C) is a significant contributor to respiratory tract infections in children and is implicated in asthma exacerbations across all age groups. Despite its impact, there is currently...
2.
Kibria M, Ali M, Haque Mollah M
PLoS One . 2024 Nov; 19(11):e0312493. PMID: 39585882
Breast cancer (BC) is yet a significant global health challenge across various populations including Ghana, though several studies on host-genome associated with BC have been investigated molecular mechanisms of BC...
3.
Mahmud S, Ajadee A, Hossen M, Islam M, Ahmmed R, Ali M, et al.
Comput Biol Chem . 2024 Oct; 113:108245. PMID: 39454454
The most frequent endocrine cancer of the head and neck is thyroid carcinoma (THCA). Although there is increasing evidence linking THCA to genetic alterations, the exact molecular mechanism behind this...
4.
Ajadee A, Mahmud S, Hossain M, Ahmmed R, Ali M, Reza M, et al.
PLoS One . 2024 Sep; 19(9):e0310843. PMID: 39348357
Clear cell renal cell carcinoma (ccRCC) is the most prevalent subtype of kidney cancer. Although there is increasing evidence linking ccRCC to genetic alterations, the exact molecular mechanism behind this...
5.
Ahmmed R, Hossen M, Ajadee A, Mahmud S, Ali M, Mollah M, et al.
Sci Rep . 2024 Aug; 14(1):19133. PMID: 39160196
Type 2 diabetes (T2D) and Clear-cell renal cell carcinoma (ccRCC) are both complicated diseases which incidence rates gradually increasing. Population based studies show that severity of ccRCC might be associated...
6.
Alamin M, Rahaman M, Ferdousi F, Sarker A, Ali M, Hossen M, et al.
PLoS One . 2024 Jul; 19(7):e0304425. PMID: 39024368
COVID-19 caused by SARS-CoV-2 is a global health issue. It is yet a severe risk factor to the patients, who are also suffering from one or more chronic diseases including...
7.
Ali M, Sheikh H, Yaseen M, Faruqe M, Ullah I, Kumar N, et al.
Molecules . 2024 Jun; 29(11). PMID: 38893400
The outbreak of SARS-CoV-2, also known as the COVID-19 pandemic, is still a critical risk factor for both human life and the global economy. Although, several promising therapies have been...
8.
Kibria M, Ali M, Yaseen M, Khan I, Bhat M, Islam M, et al.
Pharmaceuticals (Basel) . 2024 Apr; 17(4). PMID: 38675393
SARS-CoV-2 infections, commonly referred to as COVID-19, remain a critical risk to both human life and global economies. Particularly, COVID-19 patients with weak immunity may suffer from different complications due...
9.
Ali M, Susan M
ACS Omega . 2023 Sep; 8(36):32690-32700. PMID: 37720730
In this study, volumetric properties of an ionic liquid, 1-ethyl-3-methylimidazolium ethylsulfate ([Cmim]CHSO), propane-1,2-diol, and their binary mixtures were studied by measurements of density and viscosity. The excess molar volume (),...
10.
Ali M, Bates R, Crane Z, Dicus C, Gramme M, Hamel E, et al.
Bioorg Med Chem . 2005 May; 13(13):4138-52. PMID: 15878670
Twenty analogues of the natural antitumor agent dolastatin 11, including majusculamide C, were synthesized and tested for cytotoxicity against human cancer cells and stimulation of actin polymerization. Only analogues containing...